Manchester Royal Infirmary is a hospital in Manchester, England, founded by Charles White in 1752. It is now part of Manchester University NHS Foundation Trust, sharing buildings and facilities with several other hospitals.

During the past decade, Manchester Royal Infirmary conducted 276 clinical trials. In the 10-year time frame, 276 clinical trials started and 78 clinical trials were completed, i.e. on average, 28.3% percent of trials that started reached the finish line to date. In the past 5 years, 114 clinical trials started and 55 clinical trials were completed. i.e. 48.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Manchester Royal Infirmary" #1 sponsor was "Manchester University NHS Foundation Trust" with 75 trials, followed by "University of Manchester" with 21 trials sponsored, "University College, London" with 12 trials sponsored, "Children's Cancer and Leukaemia Group" with 11 trials sponsored and "Hoffmann-La Roche" with 11 trials sponsored. Other sponsors include 268 different institutions and companies that sponsored additional 186 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Manchester Royal Infirmary" #1 collaborator was "National Institute for Health Research, United Kingdom" with 23 trials as a collaborator, "Manchester University NHS Foundation Trust" with 21 trials as a collaborator, "University of Manchester" with 19 trials as a collaborator, "Cancer Research UK" with 11 trials as a collaborator and "British Heart Foundation" with 7 trials as a collaborator. Other collaborators include 418 different institutions and companies that were collaborators in the rest 307 trials.

According to Clinical.Site data, the most researched conditions in "Manchester Royal Infirmary" are "Multiple Myeloma" (9 trials), "Breast Cancer" (8 trials), "Heart Failure" (8 trials), "Brain and Central Nervous System Tumors" (7 trials) and "Abdominal Aortic Aneurysm" (6 trials). Many other conditions were trialed in "Manchester Royal Infirmary" in a lesser frequency.

Most popular intervention types in "Manchester Royal Infirmary" are "Drug" (172 trials), "Other" (88 trials), "Device" (64 trials), "Procedure" (47 trials) and "Biological" (36 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (55 trials), "radiation therapy" (10 trials), "Cyclophosphamide" (9 trials), "carboplatin" (7 trials) and "cyclophosphamide" (7 trials). Other intervention names were less common.

The vast majority of trials in "Manchester Royal Infirmary" are 367 trials for "All" genders, 23 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Manchester Royal Infirmary". undefined are not yet recruiting, 77 are recruiting, 32 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 204 completed trials in Manchester Royal Infirmary, undefined suspended trials, and 36 terminated clinical trials to date.

Out of the total trials that were conducted in Manchester Royal Infirmary, 19 "Phase 1" clinical trials were conducted, 81 "Phase 2" clinical trials and 92 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 20 trials, and there were also 102 trials that are defined as “Not Applicable".

Manchester Royal Infirmary has several departments that took part in Clinical trials: "Manchester Heart Center, Manchester Royal Infirmary" - 5 trials, "Manchester Heart Center" - 3 trials, "Manchester Diabetes Centre" - 3 trials, "Manchester Royal Infirmary; Renal Transplant Unit" - 2 trials, "Trafford General Hospital; Rheumatology" - 2 trials, "Haemophilia Centre, University Dept. of Haemophilia, Manchester Royal Infirmary" - 2 trials